Not a healthcare professional? Go to the patient or caregiver website.

DAURISMO™ Indications and Usage (glasdegib)

1 INDICATIONS AND USAGE

DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No